Cargando…
Comparison of S1 antibody titers between BNT162b2 and ChAdOx1 COVID-19 vaccination in cancer patients
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818384/ https://www.ncbi.nlm.nih.gov/pubmed/35305399 http://dx.doi.org/10.1016/j.esmoop.2022.100414 |
| _version_ | 1784645817385091072 |
|---|---|
| author | van Dam, P.A. Debie, Y. Teuwen, L. Verbruggen, L. Vanhoutte, G. Peeters, B. Croes, L. Vulsteke, C. Anguille, S. Vandamme, T. Peeters, M. |
| author_facet | van Dam, P.A. Debie, Y. Teuwen, L. Verbruggen, L. Vanhoutte, G. Peeters, B. Croes, L. Vulsteke, C. Anguille, S. Vandamme, T. Peeters, M. |
| author_sort | van Dam, P.A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8818384 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88183842022-02-07 Comparison of S1 antibody titers between BNT162b2 and ChAdOx1 COVID-19 vaccination in cancer patients van Dam, P.A. Debie, Y. Teuwen, L. Verbruggen, L. Vanhoutte, G. Peeters, B. Croes, L. Vulsteke, C. Anguille, S. Vandamme, T. Peeters, M. ESMO Open Correspondence Elsevier 2022-02-07 /pmc/articles/PMC8818384/ /pubmed/35305399 http://dx.doi.org/10.1016/j.esmoop.2022.100414 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Correspondence van Dam, P.A. Debie, Y. Teuwen, L. Verbruggen, L. Vanhoutte, G. Peeters, B. Croes, L. Vulsteke, C. Anguille, S. Vandamme, T. Peeters, M. Comparison of S1 antibody titers between BNT162b2 and ChAdOx1 COVID-19 vaccination in cancer patients |
| title | Comparison of S1 antibody titers between BNT162b2 and ChAdOx1 COVID-19 vaccination in cancer patients |
| title_full | Comparison of S1 antibody titers between BNT162b2 and ChAdOx1 COVID-19 vaccination in cancer patients |
| title_fullStr | Comparison of S1 antibody titers between BNT162b2 and ChAdOx1 COVID-19 vaccination in cancer patients |
| title_full_unstemmed | Comparison of S1 antibody titers between BNT162b2 and ChAdOx1 COVID-19 vaccination in cancer patients |
| title_short | Comparison of S1 antibody titers between BNT162b2 and ChAdOx1 COVID-19 vaccination in cancer patients |
| title_sort | comparison of s1 antibody titers between bnt162b2 and chadox1 covid-19 vaccination in cancer patients |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818384/ https://www.ncbi.nlm.nih.gov/pubmed/35305399 http://dx.doi.org/10.1016/j.esmoop.2022.100414 |
| work_keys_str_mv | AT vandampa comparisonofs1antibodytitersbetweenbnt162b2andchadox1covid19vaccinationincancerpatients AT debiey comparisonofs1antibodytitersbetweenbnt162b2andchadox1covid19vaccinationincancerpatients AT teuwenl comparisonofs1antibodytitersbetweenbnt162b2andchadox1covid19vaccinationincancerpatients AT verbruggenl comparisonofs1antibodytitersbetweenbnt162b2andchadox1covid19vaccinationincancerpatients AT vanhoutteg comparisonofs1antibodytitersbetweenbnt162b2andchadox1covid19vaccinationincancerpatients AT peetersb comparisonofs1antibodytitersbetweenbnt162b2andchadox1covid19vaccinationincancerpatients AT croesl comparisonofs1antibodytitersbetweenbnt162b2andchadox1covid19vaccinationincancerpatients AT vulstekec comparisonofs1antibodytitersbetweenbnt162b2andchadox1covid19vaccinationincancerpatients AT anguilles comparisonofs1antibodytitersbetweenbnt162b2andchadox1covid19vaccinationincancerpatients AT vandammet comparisonofs1antibodytitersbetweenbnt162b2andchadox1covid19vaccinationincancerpatients AT peetersm comparisonofs1antibodytitersbetweenbnt162b2andchadox1covid19vaccinationincancerpatients |